Biogen Balance Sheet Health
Financial Health criteria checks 5/6
Biogen has a total shareholder equity of $15.2B and total debt of $6.5B, which brings its debt-to-equity ratio to 43%. Its total assets and total liabilities are $26.6B and $11.4B respectively. Biogen's EBIT is $2.0B making its interest coverage ratio 49. It has cash and short-term investments of $1.1B.
Key information
43.0%
Debt to equity ratio
US$6.54b
Debt
Interest coverage ratio | 49x |
Cash | US$1.07b |
Equity | US$15.21b |
Total liabilities | US$11.35b |
Total assets | US$26.57b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIIB's short term assets ($6.8B) exceed its short term liabilities ($3.2B).
Long Term Liabilities: BIIB's short term assets ($6.8B) do not cover its long term liabilities ($8.1B).
Debt to Equity History and Analysis
Debt Level: BIIB's net debt to equity ratio (35.9%) is considered satisfactory.
Reducing Debt: BIIB's debt to equity ratio has reduced from 43% to 43% over the past 5 years.
Debt Coverage: BIIB's debt is well covered by operating cash flow (25.2%).
Interest Coverage: BIIB's interest payments on its debt are well covered by EBIT (49x coverage).